Kunkun Han

Title: Innovations by Kunkun Han: Pioneering CAR-NK Cell Technologies

Introduction

Kunkun Han, an esteemed inventor based in Suzhou, China, has made significant contributions to the field of biotechnology, particularly in developing innovative cancer therapies. With a strong portfolio of three patents, Han focuses on creating therapeutic agents targeting tumor cells, paving the way for improved cancer treatments with fewer side effects.

Latest Patents

Kunkun Han's latest inventions reflect his dedication to advancing cancer treatment methods. His notable patents include:

1. **Nucleotide sequences for encoding CAR, ROBO1 CAR-NK cells of expressing the CAR, and preparation and application thereof**: This invention details a nucleotide sequence for encoding chimeric antigen receptors (CARs) that can effectively target tumor cells using ROBO1 antibodies. The ROBO1 CAR-NK cells developed can specifically kill tumor cells with high ROBO1 expression, offering promising therapeutic options without common detrimental effects, such as cytokine release syndrome. This innovation presents a new era of treatment for tumors that resist conventional methods like surgery, chemotherapy, and radiotherapy.

2. **Chimeric antigen receptor cells targeting ROBO1, preparation method and use thereof**: This patent discusses enhanced CAR-T and CAR-NK cells targeting ROBO1. These cells are designed to stably express CAR elements while secreting PD-1 protein or its mutants, effectively blocking the PD-1/PD-L1 molecular interactions. Animal experiments have demonstrated these cells' significant anti-tumor effects, notably reducing tumor recurrence and improving survival rates compared to traditional ROBO1-targeted CAR-modified cells.

Career Highlights

Kunkun Han's career is marked by his commitment to research and development in cellular therapies. His work at Asclepius (Suzhou) Technology Company Group Co., Ltd. has positioned him as a leader in innovative cancer treatments. His inventions showcase his expertise in gene editing and immune cell therapy, particularly in the context of malignancies.

Collaborations

Throughout his career, Kunkun Han has collaborated with talented colleagues, including Huashun Li and Baolei Wang. Together, they have fueled advancements in therapeutic strategies, focusing on leveraging CAR technology to provide safer and more effective solutions for cancer patients.

Conclusion

Kunkun Han stands out as a pioneering inventor in the field of biotechnology. His latest patents demonstrate extraordinary potential in the fight against cancer, particularly with the development of ROBO1 CAR-NK cell therapies. His innovative approaches contribute significantly to improving cancer treatment efficacy and patient safety, marking him as a key figure in modern medical research and innovation.